Edit
ASTRA Therapeutics
https://www.astratherapeutics.com/Last activity: 31.10.2025
Probably Closed
ASTRA Therapeutics is a Drug Discovery company with a mission to design and develop novel, precision engineered drugs against a whole range of Eukaryotic Pathogens.
Location: Switzerland
Employees: 1-10
Total raised: $9.87M
Founded date: 2019
Investors 1
| Date | Name | Website |
| 09.03.2023 | Venture Ki... | venturekic... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.07.2025 | Seed | $9.71M | MIG AG |
| 04.04.2023 | - | $164.44K | - |
Mentions in press and media 12
| Date | Title | Description |
| 31.10.2025 | More than 20 Swiss biotech companies to exhibit at Bio Europe | Bio-Europe, the leading partnering conference for the global biotechnology industry, is held annually to connect biotech, pharma, investors, and service providers through one-to-one meetings, presentations, and panels. It serves as a leadi... |
| 25.07.2025 | ASTRA Therapeutics Secures €8.3 Million Seed Funding, Revolutionizing Animal Health Parasiticides | ASTRA Therapeutics, a Swiss biotech innovator, recently secured €8.3 million in seed funding. This significant capital influx fuels its vital mission: pioneering precision parasiticides for animal health. ASTRA's unique ParaX platform engin... |
| 25.07.2025 | Frisches Kapital für die Parasitenbekämpfung | Das 2022 gegründete Biotech-Startup ASTRA Therapeutics entwickelt neuartige Parasitenwirkstoffe, sogenannte Parasitizide. Zur Anwendung kommen sollen die Wirkstoffe dereinst beispielsweise in der Veterinärmedizin, wo Parasiten durch Hemmun... |
| 24.07.2025 | ASTRA Therapeutics raises CHF 7.75 million in seed financing round to advance precision Parasiticides for Animal Health | ASTRA Therapeutics raises CHF 7.75 million in seed financing round to advance precision Parasiticides for Animal Health Thu, Jul 24, 2025 10:52 CET Report this content Round co-led by MIG Capital (CHF 3 million) and Digitalis Ventures (CHF ... |
| 24.07.2025 | Swiss BioTech platform ASTRA Therapeutics raises €8.3 million to advance precision Parasiticides for animal health | Villigen-based ASTRA Therapeutics, a BioTech startup designing drugs against eukaryotic pathogens based on its proprietary platform, announced today they have raised a Seed funding round of €8.3 million. The round was led by VC firm MIG Cap... |
| 08.11.2024 | Bio-Europe: Switzerland's Biotech Showcase in Stockholm | The heart of Europe beats strong in Stockholm this November. Bio-Europe, the continent's premier partnering event for the life sciences, is back for its 30th edition. This year, it promises to be a melting pot of innovation, collaboration, ... |
| 05.11.2024 | Bio Europe in Stockholm hosts 33 Swiss companies | Currently in its 30-year-edition, BIO-Europe remains Europe's leading partnering event, for the life sciences ecosystem, providing an exceptional opportunity to explore the latest trends learn and connect with potential partners. The past ... |
| 06.05.2024 | Innosuisse funded 45 Start-up innovation projects | With the Start-up innovation project, Innosuisse directly funds high potential science-based projects initiated by Swiss start-ups, giving them a financial boost to propel their market entry. The innovation projects must be based on applic... |
| 15.05.2023 | InnoBooster to accelerate novel solutions with high potential | |
| 05.04.2023 | ASTRA Therapeutics receives funding to develop anti-parasite drugs |
Show more